Interested in learning about our Gen 3 Library Platform? Our webinar “High Quality #Antibodies Straight From Selections” shares how the platform offers developability, extremely high diversity & the exclusion of sequence liabilities. #biotechow.ly/Mcr150D5L7n
Our mission is to empower companies with visionary #antibody technologies. By using Next Generation Sequencing (#NGS) throughout construction & output analyses, we can directly measure the diversity of each exclusive library we build. #biotechow.ly/FACp50Dk9jQ
Why choose the Specifica platform? With visionary #antibody technologies, we're focused on empowering you to generate antibody drugs against any target, to create cures for any disease with our exceptional, exclusive #antibodyLibraries. #antibodiesow.ly/8ZRn50DbA1Y
Join CSO @Andrew0Bradbury & Head of Bioinformatics M Frank Erasmus for the webinar Using #NGS to Expand the Universe of Selectable #Antibodies." They'll examine the Gen 3 platform, which enables identification of leads with broad epitope coverage. #biotechow.ly/drTO50DczGT
We believe there is tremendous value to fishing in your own #antibody “pond” when selecting therapeutic leads. That’s why we offer partners exclusive libraries, created from unique donor sets not used for any other library. #antibodies#biotechow.ly/NfLE50D5Keg
A study in @NEJM of 12,500+ healthcare workers analyzed the extent to which those previously infected with #SARSCoV2 are protected from reinfection. Results: presence of anti-spike #antibodies was associated w/reduced risk in the ensuing 6 months. #biotechow.ly/eBPu50D5KyQ
Our goal in developing an #Antibody Discovery campaign is to generate as many different target-specific #antibodies as possible, w/the final product either a panel of antibodies in any format, or list of different antibody clonotype sequences. bit.ly/33LBRor#biotech
Great insights shared from Founder & CSO @Andrew0Bradbury during the recent @AntibodyEngIC Conference, where he & other industry leaders discussed “Antibody Selection & Screening in Early Discovery.” Full presentation replay available here: specifica.bio/webinars/#AntibodyEng
Comprised of five sub-libraries, our Generation 3 Library Platform has quality built in by design - offering developability, extremely high diversity, and the exclusion of sequence liabilities. bit.ly/2GkOGxu#antibodies#therapeutics#biotech
As vaccines typically require years to produce, let's recognize the scientists who are racing to produce a safe & effective #coronavirus#vaccine by next year. It’s difficult to see how pharma can go back to taking years to generate vaccines & other drugs. nyti.ms/36CXRUp
324K Followers 3K FollowingPublishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
137 Followers 287 FollowingResearcher at the Butantan Institute, Molecular immunology, Vet, MSc, PhD in Genetics, Pós-Doc UCLM and USP. MBA in health innovation. Biotecnology.
67 Followers 344 FollowingLab of Nicholas Mantis, PhD at The Wadsworth Center, NYSDOH. Researching the roles of antibodies in host-microbe interactions and protective immune responses.
26 Followers 35 FollowingEntrepreneur | Phage display and protein design | Molecular
immunology and immunotherapy | Immune receptors in cancer and autoimmunity
2K Followers 1K FollowingThe AIRR Community of The Antibody Society is a group that is coordinating stakeholders in the use of NGS technologies to study antibody and TCR repertoires.
94 Followers 222 FollowingBiotech Scientist, Nerd, Dad. Tweets are my own. Disclosure: Employed by https://t.co/4WbjwAkijv. Consultant and advisor to Scholar Rock and Ultrahuman.
706 Followers 108 FollowingBiopharma leader in the biology of the #TGFbeta superfamily of protein growth factors. Community Guidelines: https://t.co/VU9mLWhf59
313 Followers 329 FollowingMaking use of our proprietary Aeonian Rating®, we offer #selectiveantibodies (i.e. without cross-reaction!) fit for your specific requirements. https://t.co/pplAmRWd6H
35 Followers 245 FollowingHappily drowning in books | Antibody development, Cambridge UK | Team @mothersinsci | It's all about the learning and the loving |
349 Followers 868 FollowingSenior Vice President R&D @Abcam. Interested in Science. STEM. Women in leadership. Love T cells and antibodies. Woman leader. Aspiring potter.
178 Followers 939 FollowingCo-Founder and Partner at Oak Street Communications, a PR consultancy focused on mental wellness. Semi-pro kid wrangler to two tiny bosses. Meat over sizzle.
107 Followers 279 FollowingPR, Communications, Content, Social for Health and Life Science Innovators. The Seismic Collaborative is a @SpectrumScience company.
2K Followers 1K FollowingThe AIRR Community of The Antibody Society is a group that is coordinating stakeholders in the use of NGS technologies to study antibody and TCR repertoires.
2K Followers 659 FollowingThe official twitter account for the Informa Connect Antibody Engineering & Therapeutics portfolio. Your home for all things protein therapeutics.
11K Followers 2K FollowingWe’re #TeamUCB, a global biopharmaceutical company. We believe everyone deserves to live their best life.
💙 Inspired by patients 🔬 Driven by science
313 Followers 329 FollowingMaking use of our proprietary Aeonian Rating®, we offer #selectiveantibodies (i.e. without cross-reaction!) fit for your specific requirements. https://t.co/pplAmRWd6H
2K Followers 2K FollowingWe provide world leading #data that accelerates scientific #research, helping researchers, reagent suppliers, investment companies and more drive progress
127K Followers 798 FollowingBiotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
84K Followers 2K FollowingLeading research publisher empowering researchers, educators, and health professionals with our trusted brands for 180+ years. Site notice: https://t.co/UvwNQMwOxw
706 Followers 108 FollowingBiopharma leader in the biology of the #TGFbeta superfamily of protein growth factors. Community Guidelines: https://t.co/VU9mLWhf59
250K Followers 480 FollowingNature Communications is an open access journal publishing high-quality research in all areas of the biological, physical, chemical and Earth sciences.
324K Followers 3K FollowingPublishing the best of biotech science and business. Find us on Bluesky, Facebook & Instagram. Part of @SpringerNature and @NaturePortfolio.
8K Followers 2K FollowingCHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
7K Followers 583 FollowingCalifornia's biotech & life science industry leads the world in life-saving cures for diseases that impact global communities.
53K Followers 4K FollowingThe room where bio partnerships get made. Pharma BD, corporate venture, and 2,000 founders — all in San Jose, May 4–7.
https://t.co/mdobxJzlQf
20K Followers 403 FollowingScience Signaling offers researchers the most up-to-date resource for groundbreaking research and commentary in the dynamic field of cellular signaling.
349 Followers 868 FollowingSenior Vice President R&D @Abcam. Interested in Science. STEM. Women in leadership. Love T cells and antibodies. Woman leader. Aspiring potter.
71K Followers 109 FollowingCapped a 48-year journalism career with a decade-long (and counting) run as founding editor at Endpoints News. Writing a book on cancer care in America: Stage 4
28K Followers 3K FollowingProgress in science depends on new techniques, new discoveries and new ideas, probably in that order - {Sydney Brenner}. I write about biotech @MIT @techreview
16K Followers 77 FollowingSenior writer @statnews, ex-sci columnist/editor @WSJ & Newsweek; author, Can't Just Stop: An Investigation of Compulsions; Train Your Mind, Change Your Brain
22K Followers 1K FollowingScrip goes beyond the headlines to deliver insight & analysis on drug discovery, development and product life cycle value chain.
17K Followers 2K FollowingThe leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZ
53K Followers 24K FollowingHealthcare Business, Clinical and Legal News
Sign up for our e-newsletters: https://t.co/i1CnHtgPyl
Stay in the know with our daily #healthcare industry updates